Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Weight Loss Drugs
Weight Loss Drugs tag page curates three articles—Ozempic Mania, Novo Nordisk stock moves, Lilly vs Viking Therapeutics—explaining how drug trends may shape your investments.
9 articles
Lilly Novo Nordisk: Better Weight-Loss Stock Outlook
Two pharma giants sit at the center of the booming weight-loss drug market. This piece breaks down which could offer ...
Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Wall Street Analyst Thinks Viking Stock Could Soar 188%
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Lilly Just Made Game-Changing Moves in Weight-Loss Space
A big strategic shift from Lilly could redefine how investors view weight-loss drugs. This article breaks down what h...
Better Weight Loss Drug Stock: Lilly vs Viking Therapeutics
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
Ozempic Mania Reaches Olive Garden and Cheesecake Factory
Major restaurant chains are testing smaller portions as inflation and weight-management trends push diners toward val...
Why Shares Novo Nordisk Stock Sank This Week: Key Factors
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...